082800 — Vivozon Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩185bn
- KR₩224bn
- KR₩59bn
Annual cashflow statement for Vivozon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -71,015 | -39,234 | -3,357 | -9,982 | -32,424 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 56,407 | 27,559 | 7,213 | 12,511 | 17,094 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8,441 | 4,708 | -4,092 | -362 | 4,034 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17,496 | -3,323 | 2,992 | 5,731 | -6,869 |
| Capital Expenditures | -12,281 | -8,643 | -6,670 | -10,538 | -2,213 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -34,847 | -25,909 | 25,979 | 4,164 | 2,218 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -47,128 | -34,552 | 19,309 | -6,373 | 4.94 |
| Financing Cash Flow Items | -2,075 | -4,503 | -1,476 | -1,605 | -997 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13,515 | 26,391 | -16,659 | -819 | 3,477 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -50,533 | -11,448 | 5,635 | -1,462 | -3,387 |